Concepedia

Eric Ferrari

EF

17

Publications

1.4K

Citations

15

H-Index

1996

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Sarepta Therapeutics (United States)

Eric Ferrari is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1996–2013

17

Publications

17

Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice.

Ming Liu, Matthew Bryant, Jianping Chen et al. · PubMed · 1998 · 309 citations

, , +15

Characterization of Soluble Hepatitis C Virus RNA-Dependent RNA Polymerase Expressed in <i>Escherichia coli</i>

Eric Ferrari, Jacquelyn Wright-Minogue, Jane Fang et al. · Journal of Virology · 1999 · 236 citations · Full text

, , +17

De Novo Initiation of RNA Synthesis by Hepatitis C Virus Nonstructural Protein 5B Polymerase

Weidong Zhong, Annette S. Uss, Eric Ferrari et al. · Journal of Virology · 2000 · 190 citations

, , +17

Template/Primer Requirements and Single Nucleotide Incorporation by Hepatitis C Virus Nonstructural Protein 5B Polymerase

Weidong Zhong, Eric Ferrari, Charles A. Lesburg et al. · Journal of Virology · 2000 · 110 citations · Full text

Mutational Analysis of Bovine Viral Diarrhea Virus RNA-Dependent RNA Polymerase

Vicky C. H. Lai, C. Cheng Kao, Eric Ferrari et al. · Journal of Virology · 1999 · 107 citations · Full text

, , +16

Rows per page

1–5 of 17